PubMed:7537558 / 696-971
Annnotations
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T14","span":{"begin":110,"end":120},"obj":"FMAID:167267"},{"id":"_T15","span":{"begin":110,"end":120},"obj":"FMAID:62931"},{"id":"_T16","span":{"begin":110,"end":120},"obj":"FMAID:62933"},{"id":"_T17","span":{"begin":110,"end":120},"obj":"FMAID:167265"},{"id":"_T18","span":{"begin":110,"end":120},"obj":"FMAID:62932"},{"id":"_T19","span":{"begin":110,"end":120},"obj":"FMAID:167268"},{"id":"_T20","span":{"begin":112,"end":120},"obj":"FMAID:61795"},{"id":"_T21","span":{"begin":112,"end":120},"obj":"FMAID:165243"},{"id":"_T22","span":{"begin":139,"end":149},"obj":"FMAID:222825"},{"id":"_T23","span":{"begin":139,"end":149},"obj":"FMAID:179289"},{"id":"_T24","span":{"begin":139,"end":149},"obj":"FMAID:74552"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
uniprot-human
{"project":"uniprot-human","denotations":[{"id":"T2","span":{"begin":110,"end":120},"obj":"http://www.uniprot.org/uniprot/P14151"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
uniprot-mouse
{"project":"uniprot-mouse","denotations":[{"id":"T2","span":{"begin":110,"end":120},"obj":"http://www.uniprot.org/uniprot/P18337"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T5","span":{"begin":4,"end":13},"obj":"http://purl.obolibrary.org/obo/GO_0051923"},{"id":"T11","span":{"begin":14,"end":20},"obj":"http://purl.obolibrary.org/obo/GO_0097503"},{"id":"T12","span":{"begin":192,"end":198},"obj":"http://purl.obolibrary.org/obo/GO_0097503"},{"id":"T18","span":{"begin":71,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0051100"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
GO-MF
{"project":"GO-MF","denotations":[{"id":"T2","span":{"begin":112,"end":120},"obj":"http://purl.obolibrary.org/obo/GO_0030246"},{"id":"T5","span":{"begin":81,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0070026"},{"id":"T7","span":{"begin":81,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0003680"},{"id":"T9","span":{"begin":81,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0017091"},{"id":"T11","span":{"begin":81,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0005488"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":275},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":275},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":275},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
Lectin
{"project":"Lectin","denotations":[{"id":"Lectin_T2","span":{"begin":112,"end":120},"obj":"https://acgg.asia/db/lfdb/LfDB0013"},{"id":"Lectin_T5","span":{"begin":112,"end":120},"obj":"https://acgg.asia/db/lfdb/LfDB0043"},{"id":"Lectin_T8","span":{"begin":110,"end":120},"obj":"https://acgg.asia/db/lfdb/LfDB0142"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
GlycoBiology-Epitope
{"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T2","span":{"begin":130,"end":138},"obj":"id"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":275},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":275},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":275},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}
GlyCosmos15-Sentences
{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T4","span":{"begin":0,"end":275},"obj":"Sentence"}],"text":"The sulphated sialyl-Lewisx pentasaccharide produced by this procedure inhibited binding of a soluble form of L-selectin to 35SO4-labelled peripheral addressin with an IC50 of 0.8 mM, whereas sialyl-Lewisx tetrasaccharide was a weaker inhibitor, displaying an IC50 of 3.2 mM."}